Literature DB >> 24357726

Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma.

Marianne Brodtkorb1, Ole Christian Lingjærde, Kanutte Huse, Gunhild Trøen, Marit Hystad, Vera I Hilden, June H Myklebust, Ellen Leich, Andreas Rosenwald, Jan Delabie, Harald Holte, Erlend B Smeland.   

Abstract

Transformation of follicular lymphoma (FL) to a more aggressive disease is associated with rapid progression and death. Existing molecular markers for transformation are few and their clinical impact is limited. Here, we report on a whole-genome study of DNA copy numbers and gene expression profiles in serial FL biopsies. We identified 698 genes with high correlation between gene expression and copy number, and the molecular network most enriched for these cis-associated genes. This network includes 14 cis-associated genes directly related to the nuclear factor κB (NF-κB) pathway. For each of these 14 genes, the correlated NF-κB target genes were identified and corresponding expression scores were defined. The scores for 6 of the cis-associated NFκB pathway genes (BTK, IGBP1, IRAK1, ROCK1, TMED7-TICAM2, and TRIM37) were significantly associated with transformation. The results suggest that genes regulating B-cell survival and activation are involved in transformation of FL.

Entities:  

Mesh:

Year:  2013        PMID: 24357726     DOI: 10.1182/blood-2013-07-512392

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  Principles and methods of integrative genomic analyses in cancer.

Authors:  Vessela N Kristensen; Ole Christian Lingjærde; Hege G Russnes; Hans Kristian M Vollan; Arnoldo Frigessi; Anne-Lise Børresen-Dale
Journal:  Nat Rev Cancer       Date:  2014-05       Impact factor: 60.716

2.  A clinico-molecular predictor identifies follicular lymphoma patients at risk of early transformation after first-line immunotherapy.

Authors:  Chloé B Steen; Ellen Leich; June H Myklebust; Sandra Lockmer; Jillian F Wise; Björn E Wahlin; Bjørn Østenstad; Knut Liestøl; Eva Kimby; Andreas Rosenwald; Erlend B Smeland; Harald Holte; Ole Christian Lingjærde; Marianne Brodtkorb
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

Review 3.  Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Authors:  Ming-hui Li; Sheng-bo Fu; Hua-sheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

Review 4.  From genetics to the clinic: a translational perspective on follicular lymphoma.

Authors:  Sarah Huet; Pierre Sujobert; Gilles Salles
Journal:  Nat Rev Cancer       Date:  2018-02-09       Impact factor: 60.716

5.  TRIM37 promoted the growth and migration of the pancreatic cancer cells.

Authors:  Jianxin Jiang; She Tian; Chao Yu; Meiyuan Chen; Chengyi Sun
Journal:  Tumour Biol       Date:  2015-09-22

Review 6.  DUBbing Down Translation: The Functional Interaction of Deubiquitinases with the Translational Machinery.

Authors:  Bandish B Kapadia; Ronald B Gartenhaus
Journal:  Mol Cancer Ther       Date:  2019-09       Impact factor: 6.261

7.  Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics.

Authors:  Manaka Muneishi; Ayaka Nakamura; Katsumi Tachibana; Junko Suemitsu; Shinji Hasebe; Kazuto Takeuchi; Yoshihiro Yakushijin
Journal:  Int J Clin Oncol       Date:  2017-10-24       Impact factor: 3.402

8.  Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma.

Authors:  Cédric Rossi; Pauline Gravelle; Emilie Decaup; Julie Bordenave; Mary Poupot; Marie Tosolini; Don-Marc Franchini; Camille Laurent; Renaud Morin; Jean-Michel Lagarde; Loïc Ysebaert; Laetitia Ligat; Christine Jean; Ariel Savina; Christian Klein; Alba Matas Céspedes; Patricia Perez-Galan; Jean-Jacques Fournié; Christine Bezombes
Journal:  Oncoimmunology       Date:  2018-12-17       Impact factor: 8.110

9.  T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.

Authors:  Sarah E Josefsson; Kanutte Huse; Arne Kolstad; Klaus Beiske; Daniela Pende; Chloé B Steen; Else Marit Inderberg; Ole Christian Lingjærde; Bjørn Østenstad; Erlend B Smeland; Ronald Levy; Jonathan M Irish; June H Myklebust
Journal:  Clin Cancer Res       Date:  2017-12-07       Impact factor: 12.531

10.  The multitude of molecular analyses in cancer: the opening of Pandora’s box.

Authors:  Hege G Russnes; Per E Lønning; Anne-Lise Børresen-Dale; Ole C Lingjærde
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.